Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells

Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells

Glioblastoma (GBM) is the most aggressive cancer originating in the brain, but unfortunately combination treatments with resection, radiation, and chemotherapy are relatively ineffective. Therefore, novel methods of adjuvant therapy are critically needed. Cyclotides are plant-derived circular peptid...

Full description

Saved in:
Bibliographic Details
Main Authors: Samantha L. Gerlach, James S. Metcalf, Rachael A. Dunlop, Sandra Anne Banack, Cheenou Her, Viswanathan V. Krishnan, Ulf Göransson, Sunithi Gunasekera, Blazej Slazak, Paul Alan Cox
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Biomedicines
Subjects:
cyclotides
glioblastoma
temozolomide
chemosensitize
chemotherapy
adjuvant therapy
Online Access:https://www.mdpi.com/2227-9059/12/10/2216
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/12/10/2216

Similar Items